FDA Approves Weekly Exenatide Pen for Type 2 Diabetes Patients


The pre-filled, single-use pen injector eliminates the need for patients to transfer the medication between a vial and a syringe. It contains the same formulation and dose as the original Bydureon single-dose tray, providing the same continuous release of exenatide.

Read more

Posted in Drugs Glucose & Insulin Type II